Introduction: Who Should Undergo Diagnostics

If you notice blood in your urine that shows up during a routine check-up, or if you have a family member with Alport syndrome, it’s important to seek diagnostic testing. The disease is inherited, which means it runs in families. Because of this, anyone with a family history of kidney disease, hearing loss, or unexplained kidney failure should consider getting tested, even if they feel completely healthy at the moment.^[1]

Many people with Alport syndrome don’t have visible symptoms in the early stages. The condition can remain hidden for years, especially in females who carry one altered gene but have a second normal gene that partially compensates. This invisibility makes it easy to miss the disease until kidney function has already declined. That’s why doctors recommend testing for children and adults who have relatives diagnosed with Alport syndrome, or who show signs like persistent blood in their urine.^[2]

Early diagnosis matters because it allows doctors to start protective treatments sooner. These treatments cannot cure Alport syndrome, but they can help keep the kidneys working longer and delay serious complications like kidney failure, which is when the kidneys stop working and can no longer clean the blood properly. Starting medication early, even before symptoms become severe, has been shown to make a meaningful difference in how long people keep their natural kidneys.^[7]

Sometimes Alport syndrome appears for the first time in a family without any previous history. This is called a spontaneous mutation, meaning the genetic change happened in that person for the first time. In these cases, diagnosis may come later because no one expects the condition. That’s why doctors recommend investigating any unexplained blood in the urine or progressive kidney disease, even when there’s no known family history.^[2]

Diagnostic Methods

Diagnosing Alport syndrome involves several different types of tests. Doctors use a combination of urine tests, blood tests, imaging, hearing and vision exams, and sometimes tissue samples to confirm the diagnosis and understand how the disease is affecting your body.^[1]

Urine and Blood Tests

The most common first sign of Alport syndrome is blood in the urine, which doctors call hematuria. This blood is usually microscopic, meaning you can’t see it with your eyes, but it shows up when a doctor tests your urine with a special stick called a dipstick or looks at it under a microscope. Hematuria is universal in people with Alport syndrome and is often present from early infancy.^[5]

As the disease progresses, protein may also start appearing in the urine. This is called proteinuria, and it’s a sign that the kidney’s filtering system isn’t working as well as it should. Normally, kidneys keep proteins in the blood where they belong, but when the filtering membranes are damaged, proteins leak through into the urine. Proteinuria is considered an important signal that treatment should begin, even if kidney function is still normal.^[5]

Blood tests help doctors measure how well your kidneys are working overall. One key measurement is called the estimated glomerular filtration rate, or eGFR, which tells doctors how much blood your kidneys can filter in a certain amount of time. Another important blood test measures creatinine, a waste product that builds up in your blood when kidneys aren’t filtering properly. Rising creatinine levels or falling eGFR numbers indicate that kidney function is declining.^[6]

Kidney Biopsy

In the past, doctors often used a kidney biopsy to diagnose Alport syndrome. A biopsy involves removing a small piece of kidney tissue with a needle so it can be examined under a microscope. Under special electron microscopes, doctors can see that the glomerular basement membrane (the filtering structure inside the kidney) looks abnormal in people with Alport syndrome. It may appear thickened, thinned, or have an unusual appearance described as “basket-weave” because of how the collagen fibers are arranged.^[6]

However, kidney biopsies are invasive procedures that carry some risks, including bleeding and discomfort. Because of this, many doctors now prefer genetic testing, which can provide a diagnosis without the need for surgery or tissue removal. Genetic testing has become the preferred method because it’s less invasive and also reveals the exact inheritance pattern, which is important for understanding how the disease might affect other family members.^[14]

Skin Biopsy

Sometimes doctors use a skin biopsy instead of a kidney biopsy. This involves taking a small sample of skin, which is much less invasive than taking kidney tissue. The skin contains the same type of collagen that’s affected in Alport syndrome, so examining skin under a microscope can sometimes reveal the disease. However, skin biopsy isn’t always accurate, especially in females with X-linked Alport syndrome who may have normal skin collagen even though their kidneys are affected.^[6]

Genetic Testing

Genetic testing is now considered the gold standard for diagnosing Alport syndrome. This test looks directly at your DNA to find mutations in the genes responsible for producing type IV collagen. The three genes involved are called COL4A3, COL4A4, and COL4A5. Mutations in any of these genes can cause Alport syndrome.^[4]

The test is usually done with a blood sample or sometimes with a saliva sample. Lab technicians analyze your DNA to look for changes in these specific genes. If a mutation is found, it confirms the diagnosis and also tells doctors which inheritance pattern you have. This is important because X-linked Alport syndrome (caused by mutations in COL4A5) tends to be more severe in males, while autosomal forms (caused by mutations in COL4A3 or COL4A4) affect males and females more equally.^[1]

Genetic testing also helps identify family members who might be at risk. If a mutation is found in one person, doctors can test siblings, children, or other relatives to see if they carry the same mutation. This allows for early monitoring and treatment even before symptoms appear.^[2]

Family History

Taking a detailed family history is an important part of diagnosing Alport syndrome. Doctors will ask about relatives who have had kidney disease, kidney failure, hearing loss, or who needed dialysis or kidney transplants. They may also ask about any family members who died young from kidney problems. Because Alport syndrome is inherited, finding a pattern of kidney disease in multiple generations can provide strong clues that point toward this diagnosis.^[6]

In X-linked Alport syndrome, the pattern often shows more severe disease in males across generations. Females in the family may have mild symptoms like blood in the urine but may not progress to kidney failure. In autosomal recessive Alport syndrome, both parents are usually carriers without symptoms, but their children who inherit mutations from both parents can develop the disease. In autosomal dominant Alport syndrome, the disease appears in every generation, affecting both males and females.^[1]

Hearing Tests

Hearing loss is a common feature of Alport syndrome, though not everyone develops it. The hearing loss is sensorineural, which means it’s caused by damage to the inner ear structures, not to the outer ear or eardrum. It typically develops during late childhood or the teenage years and affects the ability to hear high-pitched sounds first before progressing to lower frequencies.^[4]

Doctors use a test called an audiogram to measure hearing. During this test, you wear headphones and listen to sounds at different pitches and volumes, indicating when you can hear them. The results show which frequencies are affected and how severe the hearing loss is. Regular hearing tests are recommended for people with Alport syndrome so that hearing aids can be provided when needed.^[5]

Eye Examinations

Eye abnormalities can occur in Alport syndrome, although they rarely cause vision loss. The most common finding is called anterior lenticonus, where the lens of the eye becomes cone-shaped instead of its normal round shape. Another finding is abnormal coloring of the retina, which is the light-sensitive layer at the back of the eye. These changes are usually seen in people with more severe forms of the disease.^[4]

Eye exams for Alport syndrome are typically done by an ophthalmologist, a doctor who specializes in eye diseases. They use special instruments to look at the structures inside your eye and may take photographs of your retina. If lenticonus becomes severe enough to affect vision, it can be treated by replacing the lens, similar to cataract surgery.^[5]

Diagnostics for Clinical Trial Qualification

Clinical trials are research studies that test new treatments for Alport syndrome. To participate in a clinical trial, patients must meet specific criteria that are determined through diagnostic testing. These criteria help researchers ensure that participants have the disease stage or characteristics that the trial is designed to study.^[10]

Most clinical trials require genetic confirmation of Alport syndrome. This means participants must have a documented mutation in one of the three collagen genes (COL4A3, COL4A4, or COL4A5). Some trials may focus on specific types of mutations or specific inheritance patterns, such as only enrolling people with X-linked disease or autosomal recessive disease.^[6]

Kidney function testing is also essential for clinical trial enrollment. Trials often have specific requirements for eGFR levels, which measure how well your kidneys are filtering blood. For example, a trial testing a new medication to slow kidney decline might only accept participants whose eGFR is within a certain range—not too high (meaning kidneys are still working well) and not too low (meaning kidneys have already failed). This ensures the trial can accurately measure whether the treatment is helping.^[11]

Urine testing is standard for clinical trials. Researchers typically measure the amount of protein in your urine, often expressed as a protein-to-creatinine ratio. This number helps show how much kidney damage has occurred and allows researchers to track whether an experimental treatment reduces protein leakage over time.^[7]

Blood pressure measurements are also required, since high blood pressure is both a symptom of declining kidney function and a factor that can speed up kidney damage. Some trials specifically study blood pressure medications, so participants may need to have certain blood pressure levels to qualify.^[7]

Hearing and vision tests may be part of clinical trial screening, especially if the trial is studying treatments aimed at preventing or reversing hearing loss or eye changes. These tests establish a baseline so researchers can determine if the experimental treatment has any effect on these symptoms.^[5]

Age is another common criterion. Many trials focus on children and adolescents because starting treatment early may have the greatest benefit. Other trials may focus on adults who already have more advanced disease. Knowing your age and disease stage through diagnostic testing helps determine which trials you might be eligible for.^[7]

Before enrolling in any clinical trial, participants undergo thorough screening with multiple diagnostic tests. This ensures they meet all the requirements and that the trial is safe for them. Researchers also use these tests to monitor participants throughout the study, checking for any side effects and measuring whether the treatment is working.^[10]